Publication

PARG inhibitors exhibit synthetic lethality with XRCC1 deficiency and a cellular mechanism of action that is distinct from PARP inhibition

Martin, Leenus
; 
Cheng, Tzuling
; 
James, Dominic I
; 
Begum, Habiba
; 
Smith, Kate M
; 
Jordan, Allan M
; 
Waddell, Ian D
; 
Vaidya, Kedar
; 
Fischer, Marcus
; 
Yao, Bing
... show 10 more
Citations
Altmetric:
Abstract
Authors
Martin, Leenus
Cheng, Tzuling
James, Dominic I
Begum, Habiba
Smith, Kate M
Jordan, Allan M
Waddell, Ian D
Vaidya, Kedar
Fischer, Marcus
Yao, Bing
Drummond, Jason
Cleary, Leah
Martinez, Ruben
Sutton, James
Ravindran, Nandini
Joseph, James
Venetsanakos, Eleni
Dillon, Michael
Hager, Jeffrey H
Belmont, Lisa D
Affiliation
Ideaya Biosciences, Inc., South San Francisco, CA
Description
Date
2018
Publisher
Collections
All Paterson Institute for Cancer Research
Show all metadata
Keywords
Type
Meetings and Proceedings
Citation
Martin L, Cheng T, James DI, Begum H, Smith KM, Jordan A, et al. Abstract 1943: PARG inhibitors exhibit synthetic lethality with XRCC1 deficiency and a cellular mechanism of action that is distinct from PARP inhibition. Cancer Res. 2018;78(13):1943.
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/621979
Embedded videos